Mylan To Begin Selling Generic EpiPen In Wake Of Public, Congressional Criticism
PITTSBURGH — In the wake of public criticism and congressional questions, EpiPen maker Mylan N.V. on Aug. 29 announced that it will begin selling a generic version of the epinephrine injectors...To view the full article, register now.
Already a subscriber? Click here to view full article